In view of the present coreceptor paradigm for CD4-dependent infection by HIV-1, we considered the possibility that CD4 molecules on neighboring lymphocytes may be provided to CD4 -target cells in trans, which might permit triggering of virus-cell fusion. To test this hypothesis, we first established a co-culture system in which human CD4 + T cells lacking CCR5 were mixed with HEK-293 cells expressing CCR5 and challenged with pseudotype HIV-1 bearing CCR5-dependent envelopes. Viral stocks were generated with the envelope-negative NL4-3 proviral plasmid encoding luciferase (pNL-Luc-E -R - [11] ) and plasmids encoding various HIV-1 envelopes. A very low luciferase signal was evident in 293-CCR5 cells and in the T-cell lines C8166, Sup-T1 and MT-2 upon exposure to the CCR5-dependent viral strains ADA or JRFL ( Figure  1a-c) . A large signal was generated, however, when the ADA or JRFL pseudotype viruses were used to challenge co-cultures of 293-CCR5 cells and C8166, Sup-T1 or MT-2 cells, which were used as the source of CD4. This signal, which was directly proportional to the number of cells infected, was approximately 4% of that seen when 293 cells co-expressing CCR5 and CD4 were inoculated in parallel (data not shown). Co-cultures exposed to other CCR5-dependent pseudotype viruses also yielded substantial infection signals (R.F.S. and M.A.G., unpublished observations). Thus, CD4 and CCR5 need not be expressed together on the target cell, but can cooperate when expressed on neighboring cells in trans.
Results and discussion
In view of the present coreceptor paradigm for CD4-dependent infection by HIV-1, we considered the possibility that CD4 molecules on neighboring lymphocytes may be provided to CD4 -target cells in trans, which might permit triggering of virus-cell fusion. To test this hypothesis, we first established a co-culture system in which human CD4 + T cells lacking CCR5 were mixed with HEK-293 cells expressing CCR5 and challenged with pseudotype HIV-1 bearing CCR5-dependent envelopes. Viral stocks were generated with the envelope-negative NL4-3 proviral plasmid encoding luciferase (pNL-Luc-E -R - [11] ) and plasmids encoding various HIV-1 envelopes. A very low luciferase signal was evident in 293-CCR5 cells and in the T-cell lines C8166, Sup-T1 and MT-2 upon exposure to the CCR5-dependent viral strains ADA or JRFL ( Figure  1a-c) . A large signal was generated, however, when the ADA or JRFL pseudotype viruses were used to challenge co-cultures of 293-CCR5 cells and C8166, Sup-T1 or MT-2 cells, which were used as the source of CD4. This signal, which was directly proportional to the number of cells infected, was approximately 4% of that seen when 293 cells co-expressing CCR5 and CD4 were inoculated in parallel (data not shown). Co-cultures exposed to other CCR5-dependent pseudotype viruses also yielded substantial infection signals (R.F.S. and M.A.G., unpublished observations). Thus, CD4 and CCR5 need not be expressed together on the target cell, but can cooperate when expressed on neighboring cells in trans.
To determine whether this process applies to other HIV coreceptors, we tested a CD4 -human B-cell line (Raji) that naturally expresses the coreceptor CXCR4. Raji cells alone exhibited no permissivity for pseudotype luciferase HIV-1 carrying the envelope glycoproteins of HXB2, a CXCR4-dependent strain (51 ± 31 light units (LU)/mg). But co-culture with a CXCR4 -rodent cell line engineered to express human CD4 (Rat2-CD4) permitted significant infection by the reporter virus (5,427 ± 683 LU/mg), indicating that CXCR4 and CD4 can also cooperate in trans.
We further assessed the importance of cell-surface CD4 and the coreceptor in this co-culture system by replacing MT-2 cells with HSB cells, a CD4 -T lymphoblastoid cell line, or by replacing 293-CCR5 cells with parental 293 cells, which lack CCR5 (Figure 1c) . Infection was completely prevented in both experimental conditions. In addition, the neutralizing anti-CD4 monoclonal antibody 13B.8.2 inhibited infection in the co-culture assay by more than 95% at 5 µg/ml, whereas no neutralization was seen with an isotype-matched control monoclonal antibody (data not shown).
We next determined whether such a trans-receptor mechanism could support the production of mature virions and viral spread in the culture. Co-cultures of 293-CCR5 cells and MT-2 cells were inoculated with a CCR5-dependent strain of HIV-1 (YU-2), washed extensively, and monitored for production of the HIV-1 secreted protein Gag p24 antigen (p24) over time. Abundant and progressive production of p24 was detected in supernatants of these co-cultures, which indicates that the system supported the complete viral replication cycle (Figure 1d ).
To identify the specific cell type infected in the present assay system, we used fluorescence-activated cell sorting (FACS) to separate 293-CCR5 cells and MT-2 cells that had been co-cultured and exposed to the pseudotype virus JRFL for 2 days. The co-cultures were immunostained with an anti-CD25 monoclonal antibody to define MT-2 cells and an anti-CCR5 monoclonal antibody to define 293-CCR5 cells. The cells were separated by FACS into CD25 + and CCR5 + subsets, and analyzed for luciferase content. Of the total luciferase signal, 90% was detected in the 293-CCR5 cell fraction and 10% in the MT-2 cell fraction. Therefore, the CCR5-bearing cells appear to be the predominant target of HIV-1 in these co-cultures. Within the sensitivity limits of this technology, no CD4 was detected in the CCR5 + cell fraction.
It was important to distinguish whether the infectivity by a trans-receptor mechanism requires direct cell-cell contact rather than release of cellular factors (for example, soluble forms of CD4) from the CD4 + lymphocytes. We therefore separated MT-2 cells from the 293-CCR5 cells by a semi-permeable membrane (pore size, 3 µm) that permits the diffusion of molecules and virions but not cells. Infection was detected when both cell types were plated together in the bottom chamber, but was completely prevented when the two cell types were separated by the membrane (Figure 2a) . Thus, direct cell-cell contact was mandatory to generate an effective viral receptor complex, and soluble factors released by either cell type are not sufficient to promote infection. Furthermore, serial interaction with CD4 in one chamber followed by CCR5 in the second chamber was insufficient to mediate this process.
We next investigated whether a soluble form of CD4 (sCD4) representing the D1-D4 extracellular domains of the molecule [12] could mimic CD4 + cells in these cultures. We exposed 293-CCR5 cells or 293 parental cells to the CCR5-dependent virus BaL in the presence of sCD4. The sCD4 conferred susceptibility to HIV-1 infection leading to productive replication of virus onto 293-CCR5 cells, but had no effect on cells lacking CCR5 ( Figure 2b) ; this process exhibited dose-dependence. We have also found that the amino-terminal D1 domain is both necessary and sufficient to induce infection by this pathway (U.E. and M.A.G., unpublished observations). Therefore, although optimal effects may be triggered when CD4 is membrane-bound, these results are reminiscent of earlier observations with HIV-2 [13] and strongly suggest a molecular basis by which CD4 and CCR5 cooperate in trans to permit cellular entry by HIV-1. Finally, we sought to establish whether such a process may promote infection of primary CD4 -cell types, such as astrocytes, that have been reported to be infected in vivo and thus implicated in brain pathology. Primary human fetal astrocytes were therefore isolated and immunostained for glial fibrillary acidic protein (GFAP), CD4 and HIV-1 coreceptors. Fluorescence microscopy of these cells revealed uniform (>95% of cells) expression of GFAP and CXCR4 but not of CCR5, and an absence of CD4 (S.Y.C. and M.A.G., unpublished observations). Astrocytes cultured alone and exposed to the replication-competent CXCR4-dependent virus NL4-3 exhibited no detectable intracellular p24, as detected by immunostaining (Figure 3a) . In contrast, in infected co-cultures containing primary astrocytes and CD4 + Sup-T1 cells, approximately 2-5% of the astrocytes were found to express intracellular p24, despite the persistent absence of CD4 on the cells (Figure 3b) . Moreover, infection was fully abrogated by treatment with the specific CXCR4-antagonist peptide T22 [14] (S.Y.C. and M.A.G., unpublished observations). These findings extend earlier co-cultivation studies [15] and indicate that primary astrocytes acquire susceptibility to coreceptor-dependent infection by HIV-1 upon mixing with CD4 + lymphocytes. Although it remains to be established whether this process occurs in vivo, it may represent an important pathway for entry into astrocytes and other CD4 -cells during HIV disease.
We thus describe a process by which CD4 expressed on neighboring cells appears to prime the HIV-1 envelope protein to fuse with a target cell expressing appropriate coreceptors. Although additional studies are needed to clarify and extend these principles, a cooperative transreceptor mechanism may permit HIV-1 to infect a broader range of cell types expressing chemokine receptors with low or absent CD4 in the central nervous system, lymphoid organs, inflammatory lesions, or other sites in which CD4 + cells are juxtaposed with other potential targets.
While the mechanism appears to be less efficient than the typical CD4-dependent pathway, it corresponds to the relative infrequency of HIV-infected CD4 -cells in vivo. The expanded range of targets may nonetheless contribute to disease pathogenesis and may also represent substantial Brief Communication 549 Productive infection of primary human astrocytes upon co-culture with CD4 + cells. Human fetal brain astrocytes were isolated as described [18] and cultured to 80% confluence in chamber slides. 
Materials and methods

Cells and co-culture assays
The T-cell lines C8166, MT-2 and HSB (AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH), and Sup-T1 (ATCC CRL-1942; American Type Culture Collection), were cultured in RPMI medium (Mediatech), supplemented with 10% fetal calf serum (Gemini Bio Products), 1% glutamine (Mediatech) and 1% penicillin/streptomycin (Mediatech). 293-CCR5 cells [16] were kindly provided by I. Charo. T cells (2 × 10 6 ) were added to 293-CCR5 cells that had reached a confluence of 60-80% in a well of a 6-well plate, whereupon the co-cultures were immediately challenged with pseudotype viruses. Cells were harvested 2 days after infection and were assessed for luciferase activity as previously described [17] .
Virus stocks
Pseudotype viral stocks were generated by calcium-phosphate transfection of 293T cells with the proviral plasmid pNL-Luc-E -R -containing a luciferase reporter gene and expression plasmids for ADA and JRFL gp160 envelope 
Infection in the presence of sCD4
293-CCR5 cells and parental 293 cells were plated the day prior to infection in a 24-well plate at 70,000 cells/well. The following day, sCD4 was added to the cultures at the indicated concentrations immediately prior to adding 50 µl BaL stock. The following day, cell cultures were washed twice with medium, and fresh media containing sCD4 was added. Cells were cultured for 8 more days and secreted p24 was assessed. The sCD4 (D1-D4) was kindly provided by R. Sweet (SmithKline Beecham) through the NIH AIDS Research and Reference Reagent Program.
